Altrafin AG’s American Tower AMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,625
Closed -$509K 68
2023
Q2
$509K Sell
2,625
-239
-8% -$46.7K 0.23% 56
2023
Q1
$585K Hold
2,864
0.29% 56
2022
Q4
$607K Hold
2,864
0.36% 54
2022
Q3
$615K Sell
2,864
-1,590
-36% -$409K 0.37% 55
2022
Q2
$1.14M Sell
4,454
-400
-8% -$100K 0.61% 43
2022
Q1
$1.22M Buy
4,854
+174
+4% +$42.5K 0.48% 48
2021
Q4
$1.37M Buy
+4,680
New +$1.28M 0.49% 51

Other funds holding AMT

Altrafin AG's AMT Position: Q3 2023 in Review

Altrafin AG sold out of American Tower (AMT) in Q3 2023, closing a stake of 2,625 shares — an estimated $509K sold.

Altrafin AG first reported a position in AMT in Q4 2021 and held it in 7 quarters. The position peaked at $1.37M in Q4 2021. 1,630 funds tracked by Wall St. Rank hold AMT as of Q3 2023.

  • Altrafin AG reported no remaining American Tower position as of Q3 2023 after selling out during the quarter.
  • Altrafin AG sold 2,625 American Tower shares in Q3 2023, an estimated $509K.
  • Altrafin AG first reported a position in American Tower in Q4 2021 and held it in 7 quarters.
  • Altrafin AG's American Tower position peaked at $1.37M in Q4 2021.
  • 1,630 funds tracked by Wall St. Rank held American Tower as of Q3 2023.

Based on Altrafin AG's 13F filing for Q3 2023, filed 17 Feb 2026.